Abstract: The present invention is directed to a method of using a certain compounds which are 2,19-methyleneoxy or 2,19 methylenethio bridged steroids, and related steroidal compounds as inhibitors of the enzyme steroid aromatase, 19-hydroxylase and as treatment for various estrogen dependent/mediated disorders including hormonal dependent breast cancer.
Type:
Grant
Filed:
October 26, 1999
Date of Patent:
November 6, 2001
Assignee:
Merrell Pharmaceuticals Inc.
Inventors:
Norton P. Peet, J. O'Neal Johnston, Joseph P. Burkhart